Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; The Department of Pathology, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; Ocular Oncology Service, Hyderabad, India.
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Ophthalmology. 2013 Dec;120(12):2552-2559. doi: 10.1016/j.ophtha.2013.05.015. Epub 2013 Jun 21.
To describe the clinical features, histopathology, treatment, and outcomes of ciliary body medulloepithelioma.
Retrospective study.
Forty-one patients with medulloepithelioma.
Cryotherapy, plaque radiotherapy, external beam radiotherapy, tumor removal by partial lamellar sclerouvectomy (PLSU), or enucleation.
Metastasis and death.
Of 41 patients with ciliary body medulloepithelioma, the median age at diagnosis was 5 years. The mean tumor basal diameter was 11 mm, and the mean tumor thickness was 7 mm. Related features included secondary glaucoma (n = 18, 44%), iris neovascularization (n = 21, 51%), cataract (n = 19, 46%), lens subluxation (n = 11, 27%), lens coloboma (n = 8, 20%), retrolental neoplastic cyclitic membrane (n = 21, 51%), intratumoral cysts (n = 25, 61%), and extraocular extension (n = 4, 10%). There was systemic association with pleuropulmonary blastoma in 2 cases (5%). Primary tumor treatment included enucleation (n = 21, 60%), tumor removal by PLSU (n = 8, 23%), plaque radiotherapy (n = 3, 9%), external beam radiotherapy (n = 1, 3%), cryotherapy (n = 1, 3%), or palliative chemotherapy (n = 1, 3%). In 1 case, medulloepithelioma was diagnosed histopathologically after inadvertent evisceration for blind painful eye. Subsequent treatment for residual or recurrent tumor in cases treated conservatively/inappropriately (n = 15) was necessary in 7 cases (47%). Histopathology disclosed benign features in 6 cases (20%), malignant features in 24 cases (80%), teratoid features in 11 cases (37%), and nonteratoid features in 19 cases (63%). In the 26 enucleated eyes, other features included retrolental neoplastic cyclitic membrane (n = 18, 69%), neoplastic epiretinal membrane (n = 6, 23%), and persistent hyaloid artery (n = 6, 23%). Systemic metastasis occurred in 3 cases (8%) over a mean follow-up of 49 months, all of whom presented with extrascleral extension of tumor due to mean delay in diagnosis by 39 months.
Medulloepithelioma most commonly occurs in children. Systemic association with pleuropulmonary blastoma rarely is found. Patients with extrascleral medulloepithelioma are at risk for metastasis.
描述睫状体髓上皮瘤的临床特征、组织病理学、治疗和结局。
回顾性研究。
41 名髓上皮瘤患者。
冷冻治疗、贴骨放疗、外照射放疗、部分板层巩膜切除术(PLSU)下肿瘤切除或眼球摘除。
转移和死亡。
41 名睫状体髓上皮瘤患者中,诊断时的中位年龄为 5 岁。平均肿瘤基底直径为 11mm,平均肿瘤厚度为 7mm。相关特征包括继发性青光眼(18 例,44%)、虹膜新生血管(21 例,51%)、白内障(19 例,46%)、晶状体半脱位(11 例,27%)、晶状体缺损(8 例,20%)、视网膜后肿瘤性睫状膜(21 例,51%)、肿瘤内囊肿(25 例,61%)和眼外延伸(4 例,10%)。2 例(5%)患者与胸膜肺胚细胞瘤有全身关联。原发性肿瘤治疗包括眼球摘除术(21 例,60%)、PLSU 下肿瘤切除术(8 例,23%)、贴骨放疗(3 例,9%)、外照射放疗(1 例,3%)、冷冻治疗(1 例,3%)或姑息性化疗(1 例,3%)。1 例因盲眼疼痛而意外眼球摘除,术后组织病理学诊断为髓上皮瘤。随后对 15 例保守/不适当治疗的残留或复发性肿瘤进行治疗(n=15),其中 7 例(47%)需要治疗。组织病理学显示 6 例(20%)为良性特征,24 例(80%)为恶性特征,11 例(37%)为畸胎瘤特征,19 例(63%)为非畸胎瘤特征。在 26 例眼球摘除眼中,其他特征包括视网膜后肿瘤性睫状膜(18 例,69%)、视网膜外肿瘤性膜(6 例,23%)和持续的玻璃样动脉(6 例,23%)。平均随访 49 个月后,3 例(8%)患者出现系统转移,均因平均 39 个月的延迟诊断而出现肿瘤眼外延伸。
髓上皮瘤最常发生在儿童中。与胸膜肺胚细胞瘤的全身关联很少见。有眼外髓上皮瘤的患者有转移的风险。